Back to search
FDAFDA · Food and drugs·Recall number D-0052-2015

APLENZIN® (bupropion hydrobromide), extended-release tablets, 348 mg, a) 7-count HDPE bottle (NDC 0024-5811-07), b) 30-count HDPE bottle (NDC 0024-5811-30), Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7

Published November 5, 2014 · Recall initiated: June 5, 2014

Summary

FDA records drug Class III recall D-0052-2015, published November 5, 2014 and initiated June 5, 2014. Recalling firm: Valeant Pharmaceuticals North America LLC; Status: Terminated; Reported quantity: 23,057 HDPE bottles; Lot: Lot #: a) 13E020P; Exp. 03/17 Lot #: b) 13E029P, 13E028P, 13K032P; Exp. 03/17. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Package Insert

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Valeant Pharmaceuticals North America LLC
Distributor
Nationwide
Lot
Lot #: a) 13E020P; Exp. 03/17 Lot #: b) 13E029P, 13E028P, 13K032P; Exp. 03/17
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was APLENZIN® (bupropion hydrobromide), extended-release tablets, 348 mg, a) 7-count HDPE bottle (NDC 0024-5811-07), b) 30-count HDPE bottle (NDC 0024-5811-30), Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7 recalled?

Yes. FDA published recall D-0052-2015 on November 5, 2014. Reported hazard: Labeling: Incorrect or Missing Package Insert

What should I do if I have this product?

Voluntary: Firm initiated · Letter